For Better User Experience Please Use Potrait Mode.



Know how machine learning is helping us beat chemotherapy

While machine learning has already proven its worth in many fields, be it travel, logistics or online shopping, health care is emerging as a sector where it is expected to be a game changer

August 11, 2018


For Dr Bakre Sparing Breast Cancer Patients from Chemotherapy has been a Life Calling

For Dr Manjiri Bakre, 48, founding OncoStem Diagnostics was driven by a personal experience. Within two years of diagnosis a close friend passed away at 30 due to breast cancer

July 10, 2018


A glimpse of the vision of OncoStem by Indian express

Thirty-one-year-old Marie would have undergone chemotherapy but for Dr Manjiri Bakre and her OncoStem’s CanAssist-Breast test. The test showed that the newly married woman belonged

July 08, 2018


Silicon India speaks about OncoStem

We have come a long way from the era when surgery was the only treatment modality for breast cancer and has reached several milestones akin to radiation therapy, chemotherapy

June 11, 2018


About Dr. Manjiri in Smart CEO

Sequoia Capital and Artiman Ventures-backed OncoStem Diagnostics predicts cancer recurrence in a patient through its flagship product, CanAssist. While its current focus

June 09, 2018


E27 talks about OncoStem's flag-ship product CanAssist-Breast

A close friend of Dr. Manjiri Bakre's -- a cell biology veteran with significant experience in cancer biology and drug discovery -- was diagnosed with early-stage breast cancer

June 01, 2018


Our journey so far, in an attempt to improve the quality of life of Breast Cancer Patients, covered by CNBC Awaaz

May 26, 2018


Oncostem Diagnostics Raises $6 Million Led By Sequoia India

OncoStem Diagnostics, a Bengaluru- based oncology-focused startup, has raised $6 million in a funding round led by Sequoia India. The firm is focused on personalised cancer treatment

May 21, 2018


6 million reasons why you should know this cancer scientist

Dr Manjiri Bakre's OncoStem is revolutionising breast cancer treatment in India with a test that is faster AND cheaper than what is currently available in Europe and the US

September 27, 2017


OncoStem Diagnostics raises $6 mn led by Sequoia India, plans expansion globally

OncoStem Diagnostics, a Bangalore-based health start-up on Wednesday said it has raised USD 6 million in a funding round led by Sequoia India It will use the fund to deepen its research and development

September 06, 2017

OncoStem Diagnostics launches CanAssist-Breast: an innovative Breast cancer recurrence prediction test

OncoStem Diagnostics announces the launch of its flagship product

November 30, 2016


About OncoStem Diagnostics, Published in ET

"Today in India over 90% of breast cancer patients go for chemotherapy to avoid recurrence however if you are a stage 1 cancer patient you might not have to go through

October 04, 2016


OncoStem in ABSICON 2016

OncoStem Diagnostics participated in ABSICON 2016, a Breast Cancer focused surgical oncology meeting held from July 1st-3rd at Hotel ITC Gardenia, Bangalore. Dr. Manjiri Bakre gave

July 04, 2016